David Bates is a managing partner at Tamarisc, where he invests in early stage technology companies that improve real estate and the built environment. Representative investments include Bevi, Getaway, Omni, and Serraview. He is also a partner at TMC Group, a private holding company with real estate and financial investments in the U.S. and Asia. David has transacted more than three dozen venture deals putting more than $70M to work in high-growth technology companies. Prior to Tamarisc, David was a Principal at Morningside Ventures, beginning in the biotech sector and eventually transitioning over to manage Morningside's cleantech portfolio.
While at Morningside, David was asked to join F-wave, a building technology company and Morningside portfolio company, as its Chief Strategy Officer during its move to North America and during its acquisition of Fuji Solar in Japan. Prior to joining Morningside, David worked in biotech research, holding appointments at Harvard Medical School, Massachusetts General Hospital, University of Louisville, School of Medicine, and the Georgia Institute of Technology.
David is a co-founder of three active companies, and a co-inventor of five technology patents. He holds a PhD in Chemical & Materials Engineering from the University of Auckland in New Zealand, and an MS and BS in Applied Biology from the Georgia Institute of Technology.